Viruses, bacteria, and parasites – oh my! a resurgence of interest in microbial-based therapy for cancer

por Zloza, Andrew
Publicado 2018

Infection: a Cause of and Cure for Cancer

por Newman, Jenna H., Zloza, Andrew
Publicado 2017

Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer

por Chesson, Charles B, Zloza, Andrew
Publicado 2017

Immunobiochemical Reconstruction of Influenza Lung Infection—Melanoma Skin Cancer Interactions

por Nikolaev, Evgeni V., Zloza, Andrew, Sontag, Eduardo D.
Publicado 2019

Oncolytic viruses: a new class of immunotherapy drugs

por Kaufman, Howard L., Kohlhapp, Frederick J., Zloza, Andrew
Publicado 2015

Erratum: Oncolytic viruses: a new class of immunotherapy drugs

por Kaufman, Howard L., Kohlhapp, Frederick J., Zloza, Andrew
Publicado 2016

The impact of age on a mitoxantrone-based tumor vaccine

por Stonewall, Keven, Quintero, Cecilia, Zloza, Andrew, Kaufman, Howard, Ruby, Carl
Publicado 2013

Single-step nanoparticle antigen presentation system for tumor immunotherapy

por Kohlhapp, Frederick, Huelsmann, Erica, Rudra, Jai, Nabatiyan, Arman, Zloza, Andrew
Publicado 2015

Editorial: Tumor Microenvironment and Resistance to Current Therapies

por Lasfar, Ahmed, Balan, Murugabaskar, Cohen-Solal, Karine A., Zloza, Andrew
Publicado 2019

Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma

por Bommareddy, Praveen K., Zloza, Andrew, Rabkin, Samuel D., Kaufman, Howard L.
Publicado 2019

Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression

por Giurini, Eileena F., Madonna, Mary Beth, Zloza, Andrew, Gupta, Kajal H.
Publicado 2022

Acute viral infection results in a PD-1-dependent loss of anti-tumor CD8+ T cell responses: implications for tumor immunotherapy

por Kohlhapp, Frederick, Huelsmann, Erica, Broucek, Joseph, Schenkel, Jason, Kaufman, Howard, Zloza, Andrew
Publicado 2015

IFN-λ: A New Inducer of Local Immunity against Cancer and Infections

por Lasfar, Ahmed, Zloza, Andrew, de la Torre, Andrew, Cohen-Solal, Karine A.
Publicado 2016

Role of dose selection in successful interleukin-2 immunotherapy: solving the Goldilock’s Complex

por Zloza, Andrew, Broucek, Joseph R, Huelsmann, Erica J, Hughes, Tasha, Kaufman, Howard L
Publicado 2013

Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy

por Gupta, Kajal H., Nowicki, Christina, Giurini, Eileena F., Marzo, Amanda L., Zloza, Andrew
Publicado 2021

PD-1 blockade reverses viral infection-induced loss of anti-tumor CD8+ T cell responses

por Huelsmann, Erica, Broucek, Joseph, Lacek, Andrew, Lusciks, Eugene, Saba, Johnson, Nabatiyan, Arman, Zloza, Andrew
Publicado 2013

Supramolecular Peptide Nanofibers Engage Mechanisms of Autophagy in Antigen-Presenting Cells

por Rudra, Jai S., Khan, Arshad, Clover, Tara M., Endsley, Janice J., Zloza, Andrew, Wang, Jin, Jagannath, Chinnaswamy
Publicado 2017

Interleukin-2 alters distribution of CD144 (VE-cadherin) in endothelial cells

por Kim, Dae Won, Zloza, Andrew, Broucek, Joseph, Schenkel, Jason M, Ruby, Carl, Samaha, Georges, Kaufman, Howard L
Publicado 2014

Combination immunotherapy with Interleukin-2 and CTLA-4 blockade decreases tumor growth and improves overall survival

por Broucek, Joseph R, Hughes, Tasha, Huelsmann, Erica J, Poshepny, Joseph L, Ruby, Carl E, Zloza, Andrew, Kaufman, Howard L
Publicado 2013

Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses

por Zloza, Andrew, Kim, Dae Won, Kim-Schulze, Seunghee, Jagoda, Michael C, Monsurro, Vladia, Marincola, Francesco M, Kaufman, Howard L
Publicado 2014